News & Updates

SCPC Comments on the CMS Draft 2017 Medicare Part D Call Letter

The Senior Care Pharmacy Coalition (“SCPC”) appreciates the opportunity to provide the following comments to the Center for Medicare and Medicaid Service’s (“CMS”) draft 2017 Part D Call Letter, dated February 19, 2016 (the “Call Letter”)….Read More

SCPC Praises Bipartisan Collins-Loebsack Letter Advancing Investigation of PBMs’ Anti-Competitive, Non-Transparent Pricing Practices

The Senior Care Pharmacy Coalition (SCPC) today praised U.S. Reps. Doug Collins (R-GA) and Dave Loebsack (D-IA) for issuing a letter with fourteen colleagues urging the Chairmen of the U.S. House Energy and Commerce, Ways and Means and Armed Services Committees to examine the importance of passing the MAC Transparency Act (H.R. 244) in advancing payment transparency in regard to how Pharmacy Benefit Managers (PBMs) reimburse a variety of pharmacy groups, including LTC pharmacies, for generic drugs administered to patients…Read More

House Members Want Greater Transparency on Drugs Reimbursement

Morning Consult
Sixteen House members are asking three pairs of committee leaders to consider a bill they say would improve transparency of the business partnerships between the government and pharmacy benefit managers…Read More

As Shkreli Puts Face on Drug Pricing Abuses, PBM Reimbursement Trends Analysis Prompts Long-Term Care Pharmacy Group to Call for Increased 2016 Congressional Investigation

Washington, DC — With former Turing Pharmaceuticals CEO Martin Shkreli significantly raising the public profile of prescription drug pricing abuses, the Senior Care Pharmacy Coalition (SCPC) is stepping up its criticism of anti-competitive pharmacy benefit manager (PBM) pricing practices by pointing to Avalere Health pharmacy data, which SCPC argues demonstrates PBMs’ pricing methodology leads to arbitrary and capricious reimbursement – warranting greater Congressional scrutiny and oversight in 2016…Read More

Senior Care Pharmacy Coalition (SCPC) Commends Oversight & Government Reform Committee Leaders for Examining Drug Pricing Practices

The Senior Care Pharmacy Coalition (SCPC) today commended House Oversight and Government Reform Committee Chairman Jason Chaffetz (R-UT) and Ranking Member Elijah Cummings (D-MD) for holding today’s hearing, “Developments in the Prescription Drug Market,” to examine exorbitant drug price increases and growing questions about abusive pharmacy benefit manager (PBM) pricing practices…Read More

New SCPC Letter to Grassley, Leahy Urges Support For “Ensuring Patient Access and Effective Drug Enforcement Act of 2015” (S. 483)

In a new letter to Senate Judiciary Committee Chairman Charles Grassley (R-IA) and Ranking Member Patrick Leahy (D-VT), the Senior Care Pharmacy Coalition (SCPC) urged support without amendment for the Ensuring Patient Access and Effective Drug Enforcement Act of 2015 (S. 483), introduced by U.S. Senators Orrin Hatch (R-UT) and Sheldon Whitehouse (D-RI)…Read More

MAC Prices Hit LTC Sites Hard: Margin Loss Seen

Specialty Pharmacy Continuum
Robert Warnock, PharmD, realized that he had a problem. The senior vice president of pharmacy services for PruittHealth, Dr. Warnock oversees pharmacy services for five long-term care (LTC) pharmacies affiliated with Pruitt, which operates about 100 skilled care nursing facilities in the Southeast…Read More

Drug disposal rule sets up providers for noncompliance, groups say

McKnight’s Senior Living
The government’s apparent lack of understanding about the differing characteristics among senior living settings could put some providers “perpetually in noncompliance” with a proposed federal rule regarding the disposal of unused medications, several industry groups contend…Read More

Follow-Up To Long-Term Care Pharmacy Listening Session

The Senior Care Pharmacy Coalition (SCPC), one of the organizations that participated in the Food and Drug Administration’s (FDA) August 26, 2015 “listening session” on long-term care (LTC) pharmacy (the Listening Session), submits the following supplemental information that FDA requested to further elucidate LTC pharmacy issues and the potential impacts of FDA’s Draft Repackaging Guidance on LTC patient care…Read More

Comments on EPA Proposed Rule: Management Standards for Hazardous Waste Pharmaceuticals

We support efforts to ensure proper handling of hazardous waste pharmaceuticals (HWP) in the long- term care (LTC) setting. Our members are committed to take all reasonable steps to ensure the safety of the LTC residents that we serve and to protect the environment…Read More

Twitter   LinkedIn